Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 46: 207-223, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nanjee, M. N.
Right arrow Articles by Brinton, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nanjee, M. N.
Right arrow Articles by Brinton, E. A.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2000;46:207-223.)
© 2000 American Association for Clinical Chemistry, Inc.


Articles

Very Small Apolipoprotein A-I-containing Particles from Human Plasma: Isolation and Quantification by High-Performance Size-Exclusion Chromatography

M. Nazeem Nanjee1 and Eliot A. Brinton2,a

1 Department of Cardiovascular Biochemistry, St. Bartholomew’s and The Royal London School of Medicine and Dentistry, Charterhouse Square, London EC1 M 6BQ, United Kingdom.

2 Section of Metabolism, Endocrinology, and Nutrition, 111E Carl T. Hayden VA Medical Center, 650 East Indian School Road, Phoenix, AZ 85012-1892.
a Author for correspondence. Fax 602-200-6004; e-mail eliot.brinton{at}med.va.gov

Background: Very small apolipoprotein (apo) A-I-containing lipoprotein (Sm LpA-I) particles with pre-ß electrophoretic mobility may play key roles as "nascent" and/or "senescent" HDL; however, methods for their isolation are difficult and often semiquantitative.

Methods: We developed a preparative method for separating Sm LpA-I particles from human plasma by high-performance size-exclusion chromatography (HP-SEC), using two gel permeation columns (Superdex 200 and Superdex 75) in series and measuring apo A-I content in column fractions in 30 subjects with HDL-cholesterol (HDL-C) concentrations of 0.4–3.83 mmol/L.

Results: Three major sizes of apo A-I-containing particles were detected: an ~15-nm diameter (~700 kDa) species; a 7.5–12 nm (100–450 kDa) species; and a 5.8–6.3 nm species (40–60 kDa, Sm LpA-I particles), containing 0.2–3%, 80–96%, and 2–15% of plasma total apo A-I, respectively. Two subjects with severe HDL deficiency had increased relative apo A-I content in Sm LpA-I: 25% and 37%, respectively. The percentage of apo A-I in Sm LpA-I correlated positively with fasting plasma triglyceride concentrations (r = 0.581; P <0.0005) and inversely with total apo A-I (r = -0.551; P <0.0013) and HDL-C concentrations (r = -0.532; P <0.0017), although the latter two relationships were largely attributable to extremely hypoalphalipoproteinemic subjects. The percentage of apo A-I in Sm LpA-I correlated with that in pre-ß-migrating species by crossed immunoelectrophoresis (r = 0.98; P <0.0001; n = 24) and with that in the d >1.21 kg/L fraction by ultracentrifugation (r = 0.86; P <0.001; n = 20). Sm LpA-I particles, on average, appear to contain two apo A-I and four phospholipid molecules but little or no apo A-II, triglyceride, or cholesterol.

Conclusions: We present a new HP-SEC method for size separation of native HDL particles from plasma, including Sm Lp A-I, which may play important roles in the metabolism of HDL and in its contribution(s) to protection against atherosclerosis. This method provides a basis for further studies of the structure and function of Sm Lp A-I.




The following articles in journals at HighWire Press have cited this article:


Home page
Pharmacol. Rev.Home page
A. Kontush and M. J. Chapman
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Suzuki, H. Wada, S. Maeda, K. Saito, S. Minatoguchi, K. Saito, and M. Seishima
Increased Plasma Lipid-Poor Apolipoprotein A-I in Patients with Coronary Artery Disease
Clin. Chem., January 1, 2005; 51(1): 132 - 137.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. G. Yancey, B. F. Asztalos, N. Stettler, D. Piccoli, D. L. Williams, M. A. Connelly, and G. H. Rothblat
SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome
J. Lipid Res., September 1, 2004; 45(9): 1724 - 1732.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K.-i. Okuhira, M. Tsujita, Y. Yamauchi, S. Abe-Dohmae, K. Kato, T. Handa, and S. Yokoyama
Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL
J. Lipid Res., April 1, 2004; 45(4): 645 - 652.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J.-Y. Lee, L. Lanningham-Foster, E. Y. Boudyguina, T. L. Smith, E. R. Young, P. L. Colvin, M. J. Thomas, and J. S. Parks
Pre{beta} high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice
J. Lipid Res., April 1, 2004; 45(4): 716 - 728.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. M. Gotto Jr and E. A. Brinton
Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report and update
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 717 - 724.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Hattori, T. Kujiraoka, T. Egashira, E. Saito, T. Fujioka, S. Takahashi, M. Ito, J. A. Cooper, I. P. Stepanova, M. N. Nanjee, et al.
Association of Coronary Heart Disease with Pre-{beta}-HDL Concentrations in Japanese Men
Clin. Chem., March 1, 2004; 50(3): 589 - 595.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Siggins, M. Jauhiainen, V. M. Olkkonen, J. Tenhunen, and C. Ehnholm
PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma
J. Lipid Res., September 1, 2003; 44(9): 1698 - 1704.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. Miida, O. Miyazaki, Y. Nakamura, S. Hirayama, O. Hanyu, I. Fukamachi, and M. Okada
Analytical performance of a sandwich enzyme immunoassay for pre{beta}1-HDL in stabilized plasma
J. Lipid Res., March 1, 2003; 44(3): 645 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Chetiveaux, H. Nazih, V. Ferchaud-Roucher, G. Lambert, Y. Zair, M. Masson, K. Ouguerram, D. Bouhours, and M. Krempf
The differential apoA-I enrichment of pre{beta}1 and {alpha}HDL is detectable by gel filtration separation
J. Lipid Res., November 1, 2002; 43(11): 1986 - 1993.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. N. Nanjee, C. J. Cooke, R. Garvin, F. Semeria, G. Lewis, W. L. Olszewski, and N. E. Miller
Intravenous apoA-I/lecithin discs increase pre-{beta}-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans
J. Lipid Res., October 1, 2001; 42(10): 1586 - 1593.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
W. Safi, J. N. Maiorano, and W. S. Davidson
A proteolytic method for distinguishing between lipid-free and lipid-bound apolipoprotein A-I
J. Lipid Res., May 1, 2001; 42(5): 864 - 872.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
M. N. Nanjee, C. J. Cooke, J. S. Wong, R. L. Hamilton, W. L. Olszewski, and N. E. Miller
Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: quantification of cholesterol uptake by HDL in tissue fluids
J. Lipid Res., April 1, 2001; 42(4): 639 - 648.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. N. Nanjee, C. J. Cooke, W. L. Olszewski, and N. E. Miller
Concentrations of Electrophoretic and Size Subclasses of Apolipoprotein A-I-Containing Particles in Human Peripheral Lymph
Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2148 - 2155.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.